Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.
Isabel Leroux-RoelsMarc Van RanstCorinne VandermeulenCarline Vanden AbeeleNathalie De SchrevelBruno SalaunCéline VerheustMarie-Pierre DavidShady KotbVeronica HulstrømPublished in: The Journal of infectious diseases (2023)
NCT04657198; EudraCT, 2020-000692-21.